Leukeima + Lymphoma Research
To learn more about leukemia and lymphoma and ongoing clinical trials in this area, visit our Leukemia + Lymphoma Research page.
Leukemia + Lymphoma ResearchThis is a study for participants with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have already received treatment for this disease. The main purpose is to add pirtobrutinib to other drugs that have already been approved by the United States Food and Drug Administration (US FDA), and by many other countries, for CLL/SLL.
Have chronic lymphocytic leukemia or small lymphocytic lymphoma that requires treatment
Have already had treatment for this disease
Be well enough to perform their own personal care
Have adequate organ function and blood counts, as measured by blood tests
Have cancer that has changed to different type of cancer or has spread to the brain or spinal cord
Have serious heart disease
Need a blood thinner called warfarin
Have any problems absorbing food or medicine taken by mouth
Take certain medicines that affect how fast the study drug is broken down in the body
Have active infection
To learn more about leukemia and lymphoma and ongoing clinical trials in this area, visit our Leukemia + Lymphoma Research page.
Leukemia + Lymphoma ResearchTo learn more about the different types of cancer research we conduct and ongoing clinical trials, visit our Cancer Research page.
Learn MoreA clinical trial helps us learn if a new potential medicine or treatment works and how it works. Clinical trials are also called clinical research studies. To learn more about what to expect when taking part in a clinical trial, visit our Clinical Trial Information page.